Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Pfizer to Supply $22 Million in Drugs to Covid Stockpile

Sept. 28, 2020, 3:29 PM

Pfizer Inc. will supply almost $22.2 million in drugs to the national medical stockpile to treat patients with Covid-19 and prepare for future emergencies.

The Strategic National Stockpile is purchasing the pharmaceuticals as part of a plan to restructure and resupply, known as SNS 2.0, so that there are enough in the case of future Covid-19 flare-ups.

The contract is for hydromorphone, cisatracurium, Zosyn, cefepime, dobutamine, ondansetron, dopamine, and heparin, according to the notice.

The stockpile previously awarded $81 million in contracts to Fresenius Kabi and Baxter Healthcare Corp. for drugs.

To read the full article log in.

Learn more about a Bloomberg Law subscription.